🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/03/1990 | 10,93 | 10,97 | 10,83 | 10,93 | -0,54% | 1,27% | 5.878.651 |
| 21/03/1990 | 11,09 | 11,11 | 10,99 | 10,99 | -1,07% | 1,07% | 4.041.298 |
| 20/03/1990 | 11,23 | 11,27 | 11,09 | 11,11 | -1,41% | 1,59% | 4.767.562 |
| 19/03/1990 | 11,13 | 11,29 | 11,09 | 11,27 | +0,18% | 1,78% | 4.612.248 |
| 16/03/1990 | 11,07 | 11,25 | 11,05 | 11,25 | +2,54% | 1,80% | 8.977.378 |
| 15/03/1990 | 10,89 | 10,99 | 10,87 | 10,97 | +1,10% | 1,10% | 3.307.488 |
| 14/03/1990 | 10,70 | 10,89 | 10,68 | 10,85 | +1,68% | 2,04% | 4.167.686 |
| 13/03/1990 | 10,81 | 10,85 | 10,68 | 10,68 | -2,01% | 1,65% | 4.639.915 |
| 12/03/1990 | 10,85 | 10,89 | 10,77 | 10,89 | +0,00% | 1,10% | 4.040.040 |
| 09/03/1990 | 10,91 | 10,95 | 10,87 | 10,89 | -0,72% | 0,73% | 5.402.021 |
| 08/03/1990 | 11,07 | 11,09 | 10,89 | 10,97 | -0,72% | 1,80% | 7.714.118 |
| 07/03/1990 | 11,21 | 11,23 | 11,01 | 11,05 | -1,42% | 1,95% | 4.718.515 |
| 06/03/1990 | 11,01 | 11,21 | 10,99 | 11,21 | +1,99% | 1,98% | 4.453.790 |
| 05/03/1990 | 11,05 | 11,13 | 10,99 | 10,99 | -0,72% | 1,26% | 4.878.230 |
| 02/03/1990 | 11,03 | 11,07 | 10,89 | 11,07 | +0,72% | 1,62% | 5.362.406 |
| 01/03/1990 | 10,89 | 11,05 | 10,85 | 10,99 | +1,10% | 1,82% | 6.630.696 |
| 28/02/1990 | 10,93 | 11,01 | 10,81 | 10,87 | -0,91% | 1,82% | 7.561.320 |
| 27/02/1990 | 10,93 | 11,05 | 10,89 | 10,97 | +0,73% | 1,45% | 5.200.805 |
| 26/02/1990 | 10,77 | 10,99 | 10,73 | 10,89 | +0,74% | 2,40% | 8.017.200 |
| 23/02/1990 | 11,01 | 11,05 | 10,66 | 10,81 | -2,51% | 3,61% | 10.075.891 |
| 22/02/1990 | 11,21 | 11,25 | 11,01 | 11,09 | -0,71% | 2,13% | 4.515.413 |
| 21/02/1990 | 11,13 | 11,21 | 11,07 | 11,17 | -0,88% | 1,25% | 6.255.302 |
| 20/02/1990 | 11,29 | 11,31 | 11,13 | 11,27 | -0,87% | 1,58% | 4.280.870 |
| 16/02/1990 | 11,53 | 11,55 | 11,33 | 11,37 | -1,72% | 1,90% | 6.823.738 |
| 15/02/1990 | 11,33 | 11,57 | 11,31 | 11,57 | +2,11% | 2,28% | 2.385.667 |
| 14/02/1990 | 11,33 | 11,39 | 11,29 | 11,33 | +0,00% | 0,88% | 2.911.973 |
| 13/02/1990 | 11,47 | 11,49 | 11,29 | 11,33 | -1,21% | 1,73% | 4.024.949 |
| 12/02/1990 | 11,55 | 11,59 | 11,47 | 11,47 | -1,03% | 1,03% | 2.090.131 |
| 09/02/1990 | 11,57 | 11,63 | 11,51 | 11,59 | +0,17% | 1,03% | 3.945.091 |
| 08/02/1990 | 11,57 | 11,63 | 11,51 | 11,57 | +0,00% | 1,03% | 4.268.923 |